Up to 40% of patients undergoing breast conserving surgery for breast cancer require repeat surgeries due to close to or positive margins. The lengthy processing required for evaluating surgical ...
Thermo Fisher Scientific Inc. has announced that its new Thermo Scientific STP 420ES Tissue Processor for high-throughput tissue processing has been independently validated for xylene-free protocols.